type 2 diabetes

Possible adverse effects of dpp 4 inhibitors in type 2 diabetes

Possible adverse effects of dpp 4 inhibitors in type 2 diabetes

What are incretins and incretinomimetics, which drugs from the group of dipeptidyl peptidase 4 inhibitors and glucagon-like peptide 1 agonists are used in the treatment of diabetes? Today you will learn what these long and complex words mean, and most importantly, how to apply this knowledge. This article will focus on completely new drugs-analogs of …

Possible adverse effects of dpp 4 inhibitors in type 2 diabetes Read More »

No evidence of benefit for insulin analogs over nph insulin

No evidence of benefit for insulin analogs over nph insulin

Tujeo and Tresiba are two new long-acting insulin analogs that can be prescribed to patients with type 1 and type 2 diabetes to maintain normal blood glucose levels between meals and at night. Patients with type 1 diabetes should combine this type of insulin with the insulin recommended for administration at meals – most often …

No evidence of benefit for insulin analogs over nph insulin Read More »

effectiveness of peer support in type 2 diabetes

More evidence needed on the cost effectiveness of peer support in type 2 diabetes

The modern world offers our society a global acceleration of life. Day after day passes, people build a career, live an active social life, and periodically struggle with emerging problems and diseases. In this rhythm, it is impossible not to pay attention to the fact that the younger generation often remains left to themselves. Of …

More evidence needed on the cost effectiveness of peer support in type 2 diabetes Read More »

Metformin

Metformin may be associated with a reduced risk of liver cancer in type 2 diabetes

Effectiveness and features of Metformin administration in diabetes mellitus OUR READERS RECOMMEND! . Seeing the popularity of this tool, we decided to offer it to your attention. Metformin is a vital drug for people with diabetes. The drug has a glucose-lowering effect that regulates blood sugar levels, reduces appetite and promotes active fat burning. The …

Metformin may be associated with a reduced risk of liver cancer in type 2 diabetes Read More »

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy

Metformin is widely used as a first line treatment for type 2 diabetes and it is usually continued when treatment is intensified, such as with other oral agents or by insulin therapy. This systematic review looked at whether metformin is actually beneficial to patients who are using insulin. Clinical question: In people with type 2 …

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy Read More »